Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 29876 - 29900 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Decitabine	Approved Investigational	SCG5	6447	upregulated	decitabine results in increased expression of SCG5 mRNA	15q13.3	A22027
Decitabine	Approved Investigational	SCGB3A1	92304	upregulated	decitabine results in increased expression of SCGB3A1 mRNA	5q35.3	A22022
Decitabine	Approved Investigational	SCRN1	9805	upregulated	decitabine results in increased expression of SCRN1 mRNA	7p14.3	A21919
Decitabine	Approved Investigational	SDC4	6385	upregulated	decitabine results in increased expression of SDC4 mRNA	20q13.12	A21912
Decitabine	Approved Investigational	SELL	6402	upregulated	decitabine results in increased expression of SELL mRNA	1q24.2	A20985
Decitabine	Approved Investigational	SERPINA1	5265	upregulated	decitabine results in increased expression of SERPINA1 mRNA	14q32.13	A20985
Decitabine	Approved Investigational	SERPINB2	5055	upregulated	decitabine results in increased expression of SERPINB2 mRNA	18q21.33-q22.1	A21919
Decitabine	Approved Investigational	SERPINB5	5268	upregulated	decitabine results in increased expression of SERPINB5 mRNA	18q21.33	A22028 A22029
Decitabine	Approved Investigational	SERPINE1	5054	upregulated	decitabine results in increased expression of SERPINE1 mRNA	7q22.1	A21919
Decitabine	Approved Investigational	SFRP1	6422	upregulated	decitabine results in increased expression of SFRP1 mRNA	8p11.21	A21952 A21936
Decitabine	Approved Investigational	SFRP2	6423	upregulated	decitabine results in increased expression of SFRP2 mRNA	4q31.3	A21936
Decitabine	Approved Investigational	SFRP5	6425	upregulated	decitabine results in increased expression of SFRP5 mRNA	10q24.2	A21936
Decitabine	Approved Investigational	SGSM3	27352	downregulated	decitabine results in decreased expression of SGSM3 mRNA	22q13.1	A20985
Decitabine	Approved Investigational	SH3RF2	153769	downregulated	decitabine results in decreased expression of SH3RF2 mRNA	5q32	A21913
Decitabine	Approved Investigational	SHANK3	85358	upregulated	decitabine results in increased expression of SHANK3 mRNA	22q13.33	A22030
Decitabine	Approved Investigational	SHC1	6464	upregulated	decitabine results in increased expression of SHC1 mRNA	1q21.3	A21912
Decitabine	Approved Investigational	SLA	6503	upregulated	decitabine results in increased expression of SLA mRNA	8q24.22	A20985
Decitabine	Approved Investigational	SLC12A4	6560	upregulated	decitabine results in increased expression of SLC12A4 mRNA	16q22.1	A21917
Decitabine	Approved Investigational	SLC16A1	6566	upregulated	decitabine results in increased expression of SLC16A1 mRNA	1p13.2	A21321
Decitabine	Approved Investigational	SLC16A3	9123	upregulated	decitabine results in increased expression of SLC16A3 mRNA	17q25.3	A20985
Decitabine	Approved Investigational	SLC19A1	6573	upregulated	decitabine results in increased expression of SLC19A1 mRNA	21q22.3	A21910
Decitabine	Approved Investigational	SLC25A1	6576	upregulated	decitabine results in increased expression of SLC25A1 mRNA	22q11.21	A22031
Decitabine	Approved Investigational	SLC29A2	3177	downregulated	decitabine results in decreased expression of SLC29A2 mRNA	11q13.2	A20985
Decitabine	Approved Investigational	SLC43A3	29015	upregulated	decitabine results in increased expression of SLC43A3 mRNA	11q12.1	A20985
Decitabine	Approved Investigational	SLC5A5	6528	upregulated	decitabine results in increased expression of SLC5A5 mRNA	19p13.11	A22032

Displaying entries 29876 - 29900 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability